Home » Topics » BioWorld Science

BioWorld Science
RSS

New hope for heart failure patients

Dec. 3, 1996

New hope for muscular dystrophy sufferers

Dec. 3, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

Dec. 3, 1996

Pharmacopeia reports protein farnesyl transferase inhibitors

Dec. 3, 1996

New farnesyl protein transferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

Dec. 3, 1996

Merck reveals new thrombin inhibitor series

Dec. 3, 1996

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Dec. 2, 1996

Patent issued for method of diagnosing and treating impotence

Dec. 2, 1996

Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...